Fact Sheet for Healthcare Providers: InBios International, Inc. – SCoV-2 Detect™ IgG ELISA | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: InBios International, Inc. – SCoV-2 Detect™ IgG ELISA

06/10/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/10/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SCoV-2 Detect™ IgG ELISA. The SCoV-2 Detect™ IgG ELISA is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum. (PDF)